813 Results
Sort By:
Published on March 24, 2017
The Personalized Medicine Coalition (PMC) has released findings on ways that organizations can move personalized medicine forward in the clinical setting. The report, titled “A Roadmap for Facilitating the Clinical Adoption of Personalized Medicine,” was published in the March edition of Personalized Medicine, and was based on interviews and focus…
Published on March 22, 2017
It is likely one of the longest periods of foreshadowing in science. In 1869, Australian physician Thomas R. Ashworth first observed circulating tumor cells (CTCs) in one of his patients and suggested the treasure trove of information they might contain. “Cells identical with those of the cancer itself being seen in…
Published on March 7, 2017
HudsonAlpha Institute for Biotechnology said today it is launching a clinical program for adults interested in gaining insights into their health and their responses to specific medications base on their genomic profile. Insight Genome uses whole-genome sequencing to tell patients about their risks for developing specific medical conditions, or passing…
Published on February 28, 2017
Congenica, a leading provider of clinical genome analysis technology formed to commercialize research by the U.K. Wellcome Trust Sanger Institute, said yesterday it has raised £8 million ($10 million) in Series B financing. Congenica said it will use the Series B investment to accelerate international growth and expand customer support…
Published on February 14, 2017
Precision medicine company Perthera has announced a partnership with the non-profit patient support organization Hope for Stomach Cancer that will see Perthera’s Precision Cancer Analysis (PCA) service provided to all Hope for Stomach Cancer patients at no cost to them. PCA is a service that brings together a variety of CLIA/CAP…
Published on February 9, 2017
Delivering rapid, cost-effective, and accurate analysis (as well as efficient storage) of next-generation sequencing (NGS) data is the goal of a bundled computing and storage solution recently developed by Edico Genome with Dell EMC. The exponential increase in the generation of genomic data to support research, for clinical use, and…
Published on February 8, 2017
The molecular diagnostics market is growing, though projections on how fast and how far vary depending on who is studying the field. Grand View Research in October projected a near-tripling of the market to $17.9 billion in 2024, from $6.45 billion in 2015. That’s just slightly lower than the $6.54…
Published on February 7, 2017
Genomic diagnostics company Veracyte announced that the Medicare coverage policy for its Percepta Bronchial Genomic Classifier has been finalized by Palmetto, a Medicare Administrative Contractor (MAC). According to Veracyte, the local coverage determination (LCD) makes Percepta—which was developed via the Medicare MolDx program—the first genomic lung cancer screening and diagnostic test…
Published on February 1, 2017
Guardant Health and The University of Texas MD Anderson Cancer Center said they will partner to speed up use of comprehensive liquid biopsy (CLB) technology into standard of care in cancer treatment, through a commercial R&D agreement whose value was not disclosed. Under the agreement, Guardant will help MD Anderson…
Published on January 23, 2017
Researchers at Columbia University Medical Center are set to present their recent findings this Thursday in the plenary session at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in which they uncovered that detection rate of genetic findings increased between 10 to 30 percent when fetal genomic sequencing…
Published on January 19, 2017
Agilent Technologies said it will extend its two-year-old collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium. The partners have inked a two-year extension that will focus on detecting genetic abnormalities in cell-free DNA and embryo biopsies, Agilent said…
Published on January 11, 2017
A new study by an international team of scientists lead by researchers at Columbia University Medical Center (CUMC), and New York-Presbyterian has just found that several genes previously implicated only in rare, severe forms of pediatric epilepsy also contribute to common forms of the disorder. The findings from the study…
Published on January 5, 2017
Edico Genome will partner with Dell EMC to offer a bundled compute and storage solution designed to deliver rapid, cost-effective and accurate analysis, as well as efficient storage, of next-generation sequencing data. The solution, announced yesterday, will combine Edico Genome’s DRAGEN processor integrated into a 1U Dell 4130 server for…
Published on December 14, 2016
Circulating tumor DNA (ctDNA) diagnostics company Trovagene announced this week it will eliminate 20 jobs as it restructures its business to focus on selling its test kits and systems to research institutions, cancer centers, and clinical service facilities. The company’s announcement did not specify the percentage of workforce to be…
Published on December 7, 2016
Nonprofit genomic analysis organization the Translational Genomics Research Institute (TGen) and California-based City of Hope have announced a collaboration to apply genomic research toward clinical practice through a partnership in which TGen will become a City of Hope subsidiary. The partnership aims to combine TGen’s expertise in genomic analysis and…